Passa al contenuto
Merck
Tutte le immagini(1)

Documenti

I0361000

Ipratropium bromide impurity B

European Pharmacopoeia (EP) Reference Standard

Sinonimo/i:

(1R,3r,5S,8s)-3-[[(2RS)-3-Hydroxy-2-phenylpropanoyl]oxy]-8-methyl-8-(1-methylethyl)-8-azoniabicyclo[3.2.1]octane bromide

Autenticatiper visualizzare i prezzi riservati alla tua organizzazione & contrattuali
Tutte le immagini(1)

About This Item

Formula empirica (notazione di Hill):
C20H30BrNO3
Numero CAS:
58073-59-9
Peso molecolare:
412.36
Codice UNSPSC:
41116107
NACRES:
NA.24

Grado

pharmaceutical primary standard

Famiglia di API

ipratropium

Produttore/marchio commerciale

EDQM

applicazioni

pharmaceutical (small molecule)

Formato

neat

Temperatura di conservazione

2-8°C

Cerchi prodotti simili? Visita Guida al confronto tra prodotti

Categorie correlate

Descrizione generale

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia.

Applicazioni

Ipratropium bromide impurity B EP Reference standard, intended for use in laboratory tests only as specifically prescribed in the European Pharmacopoeia.

Confezionamento

The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue.

Altre note

Sales restrictions may apply.

Prodotti correlati

N° Catalogo
Descrizione
Determinazione del prezzo

I0360000

Ipratropium bromide, European Pharmacopoeia (EP) Reference Standard

Y0000276

Ipratropium impurity A, European Pharmacopoeia (EP) Reference Standard

1347507

Ipratropium bromide, United States Pharmacopeia (USP) Reference Standard

1347518

Ipratropium bromide Related Compound A, United States Pharmacopeia (USP) Reference Standard

1347530

Ipratropium bromide Related Compound C, United States Pharmacopeia (USP) Reference Standard

1347529

Ipratropium bromide Related Compound B, United States Pharmacopeia (USP) Reference Standard

BP625

Ipratropium bromide, British Pharmacopoeia (BP) Reference Standard

BP626

8s-Isopropyl-3β-hydroxytropanium bromide, British Pharmacopoeia (BP) Reference Standard

BP1232

Ipratropium bromide Impurity D, British Pharmacopoeia (BP) Reference Standard

PHR2873

Ipratropium Bromide Related Compound C, pharmaceutical secondary standard, certified reference material

PHR3017

Ipratropium Bromide Related Compound A, pharmaceutical secondary standard, certified reference material

Pittogrammi

Exclamation mark
GHS07

Avvertenze

Warning

Indicazioni di pericolo

H302

Classi di pericolo

Acute Tox. 4 Oral

Codice della classe di stoccaggio

11 - Combustible Solids

Classe di pericolosità dell'acqua (WGK)

WGK 3

Punto d’infiammabilità (°F)

Not applicable

Punto d’infiammabilità (°C)

Not applicable

Choose from one of the most recent versions:

Certificati d'analisi (COA)

Lot/Batch Number

Sorry, we don't have COAs for this product available online at this time.

If you need assistance, please contact Servizio Clienti

Possiedi già questo prodotto?

I documenti relativi ai prodotti acquistati recentemente sono disponibili nell’Archivio dei documenti.

Visita l’Archivio dei documenti

Ralph J Panos
International journal of chronic obstructive pulmonary disease, 8, 221-230 (2013-05-10)
Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality and its treatment is critical to improve quality of life, reduce symptoms, and diminish the frequency of COPD exacerbations. Due to the harmful environmental effects of pressurized
Sanja Juric et al.
Xenobiotica; the fate of foreign compounds in biological systems, 43(9), 785-791 (2013-04-11)
Human hepatocytes that had been cold-preserved in SureTran(TM) matrix (Abcellute Ltd, Cardiff, UK) were used for studies on cell viability, cytochrome P450 (CYP) 3A4, 2B6 and 1A2 induction and hepatic drug transporters. It has recently been shown that basal CYP
Gary T Ferguson et al.
International journal of chronic obstructive pulmonary disease, 8, 139-150 (2013-05-10)
Ipratropium bromide/albuterol Respimat inhaler (CVT-R) was developed as an environmentally friendly alternative to ipratropium bromide/albuterol metered-dose inhaler (CVT-MDI), which uses a chlorofluorocarbon propellant. The objective of this study was to evaluate patient satisfaction, device usage, and long-term safety of CVT-R
Yuko Kawasumi et al.
Clinical therapeutics, 35(4), 523-531 (2013-03-16)
In the treatment of chronic obstructive pulmonary disease (COPD), tiotropium bromide has a longer duration of action than ipratropium bromide; however, tiotropium bromide is a more expensive alternative treatment. At issue is whether tiotropium reduces the risk for hospital readmissions
Predictors of adherence to inhaled medications.
John C Huetsch et al.
Journal of general internal medicine, 28(6), 759-759 (2013-03-27)
Visualizza tutti i documenti correlati

Il team dei nostri ricercatori vanta grande esperienza in tutte le aree della ricerca quali Life Science, scienza dei materiali, sintesi chimica, cromatografia, discipline analitiche, ecc..

Contatta l'Assistenza Tecnica.